CompletedNCT05643196
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- NYU Langone Health
- Condition
- Schizophrenia
CompletedNCT03526354
This study exists to see whether the medication Brexpiprazole is workable and worth testing more broadly. Researchers are trying to understand whether the medication Brexpiprazole can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Massachusetts, Worcester
- Condition
- Schizophrenia
RecruitingNCT06118268
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 39 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
RecruitingNCT06345963
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
CompletedNCT05486312
This study exists to see whether the medication CT-155 can play a useful role in care. Researchers are trying to understand whether the medication CT-155 can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
TerminatedNCT03230097
This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 16 Years to 30 Years
- Countries
- Canada, China, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
TerminatedNCT03351244
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Canada, France, Japan, South Korea, Spain, Taiwan, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
RecruitingNCT06386588
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Schizophrenia
RecruitingNCT06835556
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
Active Not RecruitingNCT06245213
This study exists to understand whether the medication ANAVEX3-71 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication ANAVEX3-71 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Anavex Life Sciences Corp.
- Condition
- Schizophrenia
CompletedNCT06136936
This study exists to see whether the medication CT-156 is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication CT-156 in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
CompletedNCT02431702
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Brazil, Mexico, United States
- Sponsor
- Janssen Scientific Affairs, LLC
- Condition
- Schizophrenia
CompletedNCT03345342
This study exists to explore whether the medication Paliperidone could improve care and understanding. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- Argentina, Australia, Brazil, Bulgaria, Czech Republic, France, China, Hungary, India, Italy, Malaysia, Mexico, Poland, Russian Federation, South Africa, South Korea, Spain, Taiwan, Turkey, Ukraine, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
CompletedNCT03571685
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Janssen Scientific Affairs, LLC
- Condition
- Schizophrenia
RecruitingNCT05284721
This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Washington State University
- Condition
- Schizophrenia
RecruitingNCT02455193
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 21 Years to 70 Years
- Countries
- United States
- Sponsor
- University of Colorado, Denver
- Condition
- Schizophrenia
CompletedNCT02647437
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Colorado, Denver
- Condition
- Schizophrenia
TerminatedNCT03220438
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
Not Yet RecruitingNCT06923891
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- Vanguard Research Group
- Condition
- Schizophrenia
Not Yet RecruitingNCT06924255
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Collaborative Neuroscience Research, LLC
- Condition
- Schizophrenia
CompletedNCT00688259
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
TerminatedNCT05462340
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Washington University School of Medicine
- Condition
- Schizophrenia
CompletedNCT06572449
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
CompletedNCT06107803
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Minerva Neurosciences
- Condition
- Schizophrenia
CompletedNCT03245437
This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia